ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

BlackRock, Inc.'s Holding History (CIK: 0002012383)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 13,050,000 Value ($000) $19,187 Avg Close Range
Q3 2025
Shares 10,000,000 Value ($000) $16,435 Avg Close Range
Q2 2025
Shares 9,950,000 Value ($000) $12,925 Avg Close Range
Q1 2025
Shares 13,385,000 Value ($000) $15,413 Avg Close Range
Q4 2024
Shares 35,050,000 Value ($000) $37,257 Avg Close Range
Q3 2024
Shares 57,020,000 Value ($000) $66,656 Avg Close Range